Eric Duane Foster, chief commercial officer of Ardelyx Inc., disposed of 8,562 common shares on August 21, 2026, in an automatic sell-to-cover transaction to settle withholding taxes on vested restricted stock units. The sale generated proceeds of $33,022 at a weighted average price of $3.8569 per share, with individual trades ranging from $3.648 to $3.984.
Foster retained a beneficial interest in 409,410 ordinary shares of Ardelyx following the transaction. The company’s stock has declined 43% over the past six months, with Ardelyx’s shares last quoted at $3.73 in the 52-week range.
Ardelyx reported a 31% year-over-year increase in second-quarter revenue, totaling a record $118 million, though the company revised its full-year guidance for its IBSRELA treatment and withdrew its revenue target for XPHOZAH. Options activity on Ardelyx reached 11,147 contracts traded, the highest since April 2025, according to InvestingPro data.
